Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PESTI Trial
NCT05334485Phase 3Recruiting
- Start
- Sep 2024
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pyridostigmine in postoperative ileus (POI). Started Sep 2024; status: recruiting.
02
Drugs
pyridostigmine
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on NCT05334485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05334485.